Do Pharmaceutical Companies Profit from the Covid19 Crisis?
Vývoj cien akcií farmaceutických spoločností. Výkyvy na akciovom trhu zohľadnené výpočtom návratnosti investícií medzi všetkými dňami v marci 2020 a novembrom 2021. Tieto denné výkyvy v súvislosti s vývojom akciového trhu v marci 2020 prinášajú možnosť zvýšiť ročné výnosy dvojnásobne až štvornásobne...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Do Pharmaceutical Companies Profit from the Covid19 Crisis?
- The Impacts of Pharmaceutical Companies on Economic Recovery after COVID-19
- The Impact of Innovation on the Profitability of Slovak Pharmaceutical Companies
- Exit Routes, Investor Type, and the Covid-19 Crisis: Insights From UK Equity-Funded Companies
- Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic
- First Impacts of the Covid19 Crisis on Economic Growth in Central and Eastern European Countries (from Forecasts to Reality)
- Accelerated Knowledge Exchange in Times of Crisis – Lessons from COVID-19 Pandemic